Gastrointestinal Endoscopy Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

Gastrointestinal Endoscopy Market Summary

Gastrointestinal endoscopy encompasses devices like gastroscopes, colonoscopes, and sigmoidoscopes used for diagnosing and treating digestive tract conditions. The gastrointestinal endoscopy industry is characterized by its role in minimally invasive procedures, offering high diagnostic accuracy and therapeutic capabilities. Key trends include high-definition imaging, single-use endoscopes, and AI integration for enhanced diagnostics. The market is driven by rising gastrointestinal disorders, aging populations, and healthcare infrastructure growth, though it faces challenges from high costs, infection risks, and regulatory complexities.

Market Size and Growth Forecast
The global Gastrointestinal Endoscopy market was valued at USD 16.5–28.7 billion in 2024, with an estimated CAGR of 6.5%–8.5% from 2025 to 2030, driven by hospital applications.

Regional Analysis
North America is projected to grow at a CAGR of 6.3%–8.3%, with the U.S. leading due to advanced healthcare systems. Trends focus on single-use endoscopes.
Europe is expected to achieve a CAGR of 6.0%–8.0%, with Germany and the UK driving growth through diagnostic advancements. The region emphasizes AI integration.
Asia Pacific is anticipated to record the highest growth at 7.0%–9.0%, led by China and Japan, where gastrointestinal disorders are rising. Trends include cost-effective solutions.
Rest of the World is expected to grow at a CAGR of 5.8%–7.8%, supported by healthcare modernization in Latin America.

Application Analysis
Hospitals are estimated to grow at a CAGR of 6.5%–8.5%, driven by diagnostic and therapeutic needs. Trends focus on AI-enhanced endoscopy.
Diagnostic imaging centers are projected to expand at a CAGR of 6.3%–8.3%, fueled by outpatient services. Innovations include high-definition systems.
Orthopedic clinics are expected to grow at a CAGR of 6.0%–8.0%, supported by specialized diagnostics. Developments include single-use devices.
Other applications, like ambulatory centers, are anticipated to grow at a CAGR of 5.8%–7.8%, with trends toward minimally invasive solutions.

Key Market Players
Olympus, based in Tokyo, Japan, produces gastrointestinal endoscopes with high-definition imaging for hospitals.
Fujifilm, headquartered in Tokyo, Japan, offers endoscopes with advanced visualization technologies.
PENTAX Medical, located in Tokyo, Japan, supplies endoscopes for diagnostic centers, focusing on ergonomic designs.
SonoScape Medical Corp., based in Shenzhen, China, manufactures endoscopes for cost-effective diagnostics.
Shanghai Aohua, headquartered in Shanghai, China, provides endoscopes for emerging markets, emphasizing affordability.

Porter’s Five Forces Analysis
● Threat of New Entrants: Low; high capital and regulatory barriers limit entry.
● Threat of Substitutes: Moderate; alternative diagnostics like CT compete, but endoscopes’ precision maintains their edge.
● Buyer Power: Moderate; hospitals negotiate, but specialized devices limit leverage.
● Supplier Power: Moderate; imaging and material suppliers have some influence.
● Competitive Rivalry: High; players differentiate through imaging and single-use technologies.

Market Opportunities and Challenges
Opportunities
● Rising gastrointestinal disorders drive endoscopy adoption.
● Advancements in single-use and AI-integrated endoscopes enhance market opportunities.
● Emerging markets in Asia Pacific offer growth potential due to healthcare expansion.
Challenges
● High costs of advanced endoscopes limit adoption in smaller facilities.
● Infection risks from reusable devices increase regulatory scrutiny.
● Regulatory hurdles for medical devices complicate market entry.

Growth Trend Analysis
The Gastrointestinal Endoscopy market is growing steadily. On July 17, 2024, EvoEndo released the Model LE 85 Single-Use Gastroscope for sedation-free transnasal endoscopy. On August 15, 2024, Fiona Stanley Fremantle Hospitals Group expanded its digital pathways for endoscopy units. On April 30, 2025, FUJIFILM launched the EG-840T and EG-840TP gastroscopes with enhanced visualization. On June 9, 2025, UCLH Private Healthcare launched a diagnostic endoscopy service, including gastroscopy and colonoscopy. These align with a projected CAGR of 6.5%–8.5% through 2030. Show more